secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-06-05T23:59:59+00:00
Accession:  0001683168-24-003998
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals announces 1-for-50 reverse stock split effective June 4, 2024 to meet Nasdaq minimum bid price
--------------------------------------------------------------------------------

- 1-for-50 reverse stock split effective 4:01 PM ET June 4, 2024; trading on split-adjusted basis from June 5, 2024 under symbol CNSP.
- Outstanding shares reduced from ~16.25M to ~325K; authorized shares remain 300M; par value unchanged at $0.001.
- No fractional shares issued; fractional shares rounded up to nearest whole share.
- Split intended to increase per share trading price to comply with Nasdaq minimum bid price listing requirement.
- Warrants and equity awards proportionally adjusted: shares underlying divided by 50, exercise price multiplied by 50.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824003998/0001683168-24-003998-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824003998/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-003998

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer